Product Images Ponvory

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Ponvory NDC 50458-720 by Janssen Pharmaceuticals, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - ponesimod 01

Chemical Structure - ponesimod 01

PRINCIPAL DISPLAY PANEL - 20 mg Tablet Bottle Carton - ponesimod 02

PRINCIPAL DISPLAY PANEL - 20 mg Tablet Bottle Carton - ponesimod 02

Each tablet of & Ponvory® (ponesimod) contains 20 mg of the active ingredient made in Austria. This package contains 30 film-coated tablets and is child-resistant. The tablets should be stored in the original package at a temperature between 20°C and 25°C (68°F to 77°F) and should not be exposed to moisture. Excursions between 15°C to 30°C (59°F to 86°F) are permitted but should be avoided. Rxonly. Includes enclosed Medication Guide.*

PRINCIPAL DISPLAY PANEL - Kit Carton - ponesimod 03

PRINCIPAL DISPLAY PANEL - Kit Carton - ponesimod 03

The text contains information about a medication called Ponvory, which comes in a 14-day starter pack with tablets of different dosages (2mg, 3mg, 4mg, 6mg, 7mg, 8mg, 9mg, and 10mg). The medication guide should be given to each patient, and the tablets are film-coated. The rest of the text appears to be distorted or gibberish and is not readable.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.